1.本数据库收录EMA集中程序以及经HMA协调通过互认可程序或分权程序获得批准上市的药品
2.查询欧盟成员国上市的相关信息，点击欧盟成员国上市
掌握医院、零售、 电商 三大终端市场的销售脉搏，就用 药品市场全终端分析系统 (←点击链接免费试用)
全面洞察药品零售数据，助力企业精准决策，把握市场增长，就用穿云众客-零售药品消费分析决策系统(←点击链接免费试用)
| 商标名 | 通用名称 | 中文名称 | ATC编码 | 授权日期 | 上市许可持有人 | 市场状态 |
|---|---|---|---|---|---|---|
| Terrosa | teriparatide | 特立帕肽 | H05AA02 | 2017-01-04 | Gedeon Richter Plc. | Authorised |
| Dupixent | dupilumab | 度普利尤单抗 | D11AH05 | 2017-09-26 | Sanofi Winthrop Industrie | Authorised |
| MabThera | rituximab | 利妥昔单抗 | L01XC02 | 1998-06-02 | Roche Registration GmbH | Authorised |
| Ocrevus | ocrelizumab | 奥瑞珠单抗 | L04AG08 | 2018-01-08 | Roche Registration GmbH | Authorised |
| Kadcyla | trastuzumab emtansine | 恩美曲妥珠单抗 | L01XC14 | 2013-11-15 | Roche Registration GmbH | Authorised |
| Vegzelma | bevacizumab | 贝伐珠单抗 | L01XC07 | 2022-08-17 | Celltrion Healthcare Hungary Kft. | Authorised |
| Polivy | polatuzumab vedotin | 维泊妥珠单抗 | L01FX14 | 2020-01-16 | Roche Registration GmbH | Authorised |
| Elebrato Ellipta | fluticasone furoate;umeclidinium;vilanterol | R03AL08 | 2017-11-15 | GlaxoSmithKline Trading Services Limited | Authorised | |
| Suliqua | insulin glargine;lixisenatide | 甘精胰岛素;利司那肽 | A10AE54 | 2017-01-11 | Sanofi Winthrop Industrie | Authorised |
| Trelegy Ellipta | fluticasone furoate;umeclidinium;vilanterol | R03AL08 | 2017-11-15 | GlaxoSmithKline Trading Services | Authorised | |
| Pradaxa | dabigatran etexilate | 甲磺酸达比加群酯 | B01AE07 | 2008-03-17 | Boehringer Ingelheim International GmbH | Authorised |
| Zynlonta | loncastuximab tesirine | 替朗妥昔单抗 | L01FX22 | 2022-12-20 | Swedish Orphan Biovitrum AB | Authorised |
| Hexacima | diphtheria, tetanus, pertussis (acellular, component), hepatitis B (rDNA), poliomyelitis (inactivated) and Haemophilus influenzae type b conjugate vaccine (adsorbed) | J07CA09 | 2013-04-17 | Sanofi Winthrop Industrie | Authorised | |
| NovoRapid | insulin aspart | 门冬胰岛素 | A10AB05 | 1999-09-07 | Novo Nordisk A/S | Authorised |
| Blincyto | blinatumomab | 贝林妥欧单抗 | L01FX07 | 2015-11-23 | Amgen Europe B.V. | Authorised |
| Xolair | omalizumab | 奥马珠单抗 | R03DX05 | 2005-10-25 | Novartis Europharm Limited | Authorised |
| PreHevbri | hepatitis B surface antigen | J07BC01 | 2022-04-25 | VBI Vaccines B.V. | Withdrawn | |
| Hexyon | diphtheria, tetanus, pertussis (acellular, component), hepatitis B (rDNA), poliomyelitis (inactivated) and Haemophilus influenzae type b conjugate vaccine (adsorbed) | J07CA09 | 2013-04-17 | Sanofi Winthrop Industrie | Authorised | |
| Darzalex | daratumumab | 达雷妥尤单抗 | L01FC01 | 2016-05-20 | Janssen-Cilag International N.V. | Authorised |
| Keppra | levetiracetam | 左乙拉西坦 | N03AX14 | 2000-09-29 | UCB Pharma SA | Authorised |
